Wellcome commits £10 million to DNDi to develop new generation of oral leishmaniasis drugs
Geneva/London - 5 February 2019 - Wellcome has committed over £10 million to the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development...





